• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Month: November 2019

Finance

Caelus Health and Nestlé Health Science sign exclusive global development & option agreement

November 27, 2019 Microbiome Times

Caelus Health, which develops food supplements and pharmaceutical products for the prevention, early treatment and management of cardio-metabolic diseases, is entering into a strategic collaboration with Nestlé Health Science (NHSc). The aim is to further […]

Pharma & Human Health

TargEDys, a French microbiome start-up, collects the award for “Best Nutraceutical Product of the Year”

November 25, 2019 Microbiome Times

EnteroSatys® was named “Best Nutraceutical Product of the Year” at Food Matters Live Awards 2019. The awards ceremony took place on Tuesday 19 November at ExCeL London as a part of a broader event, now […]

Pharma & Human Health

Preliminary Safety and Clinical Observations From 4D pharma’s Phase I/II Study of MRx0518 in Combination With KEYTRUDA®

November 21, 2019 Microbiome Times

4D pharma plc (AIM: DDDD), a clinical-stage pharmaceutical company leading the development of Live Biotherapeutics, today announced preliminary safety and clinical observations from an ongoing Phase I/II clinical trial, in collaboration with MSD, a tradename […]

Finance

Cognate BioServices announces acquisition of Cobra Biologics

November 21, 2019 Microbiome Times

Cognate BioServices (Cognate), a leading contract development and manufacturing organization (CDMO) specialized in cell and cell-mediated gene therapy products and Cobra Biologics (Cobra), a leading CDMO specialized in providing manufacturing services for plasmid DNA and […]

Pharma & Human Health

Beware probiotics in ICU patients

November 20, 2019 Microbiome Times

It’s become common for patients in the intensive care unit (ICU), both children and adults, to receive probiotics. Often, they are started at home to counteract diarrhea caused by antibiotics. There is also interest in […]

Finance

BIOCODEX enters exclusive negotiations for the acquisition of Laboratoires IPRAD

November 20, 2019 Microbiome Times

Laboratoires IPRAD and BIOCODEX have entered into exclusive negotiations on the acquisition of Laboratoires IPRAD by Biocodex. Biocodex and Laboratoires IPRAD have complementary product portfolios in the field of family health. The two companies together […]

Pharma & Human Health

Fecal transplantation to treat patients with Parkinson’s disease: Hope or hype?

November 19, 2019 Microbiome Times

Constipation is a common complaint in patients with Parkinson’s disease (PD). Fecal microbiome transplantation (FMT) and pre- and probiotics are potential options for treating constipation and restoring the microbiome of patients with Parkinson’s disease (PD), […]

Editor's Choice

5-minute Microbiome Science Roundup: October 2019

November 18, 2019 Kristina Campbell

Below are October’s must-read scientific papers on the microbiome and human health. The first highlighted paper this month expands what we know about viruses, the tiniest members of the gut microbiota, which are often eclipsed […]

Pharma & Human Health

Doctors Come Together at FDA During C.diff Awareness Month, Advocate for Treatments

November 18, 2019 Microbiome Times

Several doctors spoke before the FDA in Washington D.C. on November 4, advocating for C.diff treatment improvements. Among those in attendance were gastroenterologists Paul Feuerstadt (Yale), Colleen Kelly (Brown), Sahil Khanna (Mayo Clinic), Jessica Allegretti […]

Finance

Arranta Bio announces the acquisition of Captozyme™, creating a Center for microbiome development and clinical supply

November 15, 2019 Microbiome Times

Arranta Bio (“Arranta”) announced today the acquisition of Captozyme™, and with it the establishment of Arranta’s Center of Excellence for process and analytical development and early clinical supply for microbiome clients with the transfer of […]

Pharma & Human Health

J. Craig Venter Institute and UC San Diego Develop Phage Treatment as Potential Cure for Alcoholic Liver Disease

November 14, 2019 Microbiome Times

Scientists from the J. Craig Venter Institute (JCVI), a not-for-profit genomic research organization, UC San Diego, and a variety of international and national academic centers published a paper today in the journal Nature describing how […]

Posts navigation

1 2 »

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • EXPERT’Biome CDMO by Lallemand at Microbiome Times Forum
    June 23, 2025
  • DynaMAP – Precision Metagenomics beyond Sequencing
    May 27, 2025
  • The Selection of a Pre-Clinical Model is Driven by the Specific Research Question
    May 13, 2025
  • Mental Health and the Brain-Gut-Microbiota Axis: Fundamental Importance of Diet
    April 3, 2025
  • Novel In vitro Model Replicates Intestinal Microbiota Composition Without Requiring Anaerobic Incubation
    March 25, 2025
sign up

Sign up to the Microbiome Times newsletter